Vanderbilt University

Displaying 11 - 20 of 26


Engineering undergrads from DIIGI lab present their research at SPIE Photonics

A new device that can image diseases of the retina more quickly will soon be tested during ophthalmic surgeries with Vanderbilt Eye Institute collaborators.

The prototype was designed by a Vanderbilt engineering undergraduate, who is first author on a paper about the work she will present today at the largest photonics conference in the world.


Study may point to new ways to reverse insulin resistance

Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.


A cataract-heart connection

If you’ve kept up with science-related news lately, then you’ve probably heard about CRISPR-Cas9, the latest and greatest new tool for gene editing.


VUSM Innovators Speaker Series February 2nd

The next installment of the Vanderbilt University School of Medicine’s Enabling Innovations Initiative (eI2) speaker series is set for Friday, February 2nd at 3PM in Light Hall 214.  eI2 is SOM’s new program to promote a culture of innovations and dissemination of new knowledge and discovery through entrepreneurial pathways.  The February 2nd Seminar will feature Dr.


Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment

Vanderbilt University has signed separate licensing and research collaboration agreements with Lundbeck, a global pharmaceutical company based in Denmark, to develop a novel approach for treating schizophrenia.

Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed by the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) that act on a receptor in the brain that has been implicated in schizophrenia.


Investigators eye new target for treating movement disorders

Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson’s disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported.

Their findings, published recently in the journal Neuron, focus on M4, a subtype of the muscarinic acetylcholine family of nerve cell (neuron) receptors activated by binding the neurotransmitter acetylcholine.


Featured Technology: The Adventures of Jasper Woodbury help students conquer math

The Adventures of Jasper Woodbury is a software-based learning tool that helps students conquer mathematical problem solving skills through project-based learning -- a teaching method that asks students to identify and solve real-world problems. 


VU@EC: Engineering student grabs first seat

At just 20 years old, Vanderbilt engineering student Ben Whittle has become the first candidate accepted into the VU@EC program.